Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate Cancer
Completed · Phase 2
Conditions studied: Prostate Cancer
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Randomized phase II trial to study the effectiveness of combination chemotherapy consisting of paclitaxel, etoposide, and estramustine as compared with ketoconazole plus doxorubicin, vinblastine, and estramustine in treating patients with prostate cancer.
Key facts
- Study ID
- NCT00003084
- Run by
- M.D. Anderson Cancer Center
- People needed
- 75
- Starts
- 1997-12-01
- Expected to finish
- 2002-11-01
- Last updated by the study team
- 2012-07-30
Who can join
Age: 18 and older. Sex: male. Healthy volunteers: not accepted.
Where it is running
- University of Texas - MD Anderson Cancer Center — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.